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ARTICLE
Haploid genetic screens identify SPRING/
C12ORF49 as a determinant of SREBP signaling
and cholesterol metabolism
Anke Loregger1,11, Matthijs Raaben2,11, Joppe Nieuwenhuis 2,11, Josephine M.E. Tan1, Lucas T. Jae 2,3,
Lisa G. van den Hengel2, Sebastian Hendrix 1, Marlene van den Berg1, Saskia Scheij1, Ji-Ying Song4,
Ivo J. Huijbers 5, Lona J. Kroese5, Roelof Ottenhoff1, Michel van Weeghel 6, Bart van de Sluis 7,8,
Thijn Brummelkamp2,9,10,12✉ & Noam Zelcer 1,12✉
The sterol-regulatory element binding proteins (SREBP) are central transcriptional regulators
of lipid metabolism. Using haploid genetic screens we identify the SREBP Regulating Gene
(SPRING/C12ORF49) as a determinant of the SREBP pathway. SPRING is a glycosylated Golgi-
resident membrane protein and its ablation in Hap1 cells, Hepa1-6 hepatoma cells, and
primary murine hepatocytes reduces SREBP signaling. In mice, Spring deletion is embryonic
lethal yet silencing of hepatic Spring expression also attenuates the SREBP response.
Mechanistically, attenuated SREBP signaling in SPRINGKO cells results from reduced SREBP
cleavage-activating protein (SCAP) and its mislocalization to the Golgi irrespective of the
cellular sterol status. Consistent with limited functional SCAP in SPRINGKO cells, reintro-
ducing SCAP restores SREBP-dependent signaling and function. Moreover, in line with the
role of SREBP in tumor growth, a wide range of tumor cell lines display dependency on
SPRING expression. In conclusion, we identify SPRING as a previously unrecognized mod-
ulator of SREBP signaling.
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Cellular sterol and fatty acid levels must be tightly con-trolled to ensure that these meet metabolic and growthdemands1. Accordingly, loss of lipid homeostasis is asso-
ciated with a wide range of human conditions, including cancer,
neurodegeneration, and cardiovascular disease. The sterol-
regulatory element binding proteins (SREBPs) are a family of
transcription factors that control all facets of lipid metabolism by
regulating the expression of a panel of genes that contain a sterol
regulatory element (SRE) in their respective promoter regions2–4.
There are three SREBP isoforms, SREBP1a, SREBP1c, and
SREBP24–6, which are structurally similar, but activate a distinct
set of genes and exhibit a divergent tissue distribution in vivo.
SREBP1c primarily regulates genes implicated in fatty acid
synthesis such as fatty acid synthase (FASN) and acetyl-CoA
carboxylase (ACC)5. In contrast, SREBP2 is primarily implicated
in the regulation of genes linked to cholesterol synthesis and
uptake, including those encoding for the rate-limiting enzymes in
cholesterol biosynthesis, 3-hydroxy-3-methylglutaryl-coenzyme
A reductase (HMGCR) and squalene epoxidase (SQLE), and the
low-density lipoprotein receptor (LDLR)6. The third isoform,
SREBP1a, regulates genes involved in both sterol and fatty acid
metabolism4.
SREBPs are produced in their precursor form as membrane-
associated endoplasmic reticulum (ER)-resident proteins that
contain an N-terminal basic helix-loop-helix leucine zipper
domain and a regulatory carboxyterminal region5. Under con-
ditions of sufficient cellular sterols, SREBPs are retained in the ER
through formation of a tripartite complex with the sterol-sensing
SREBP cleavage-activating protein (SCAP)7,8, and the ER anchor
proteins insulin-induced genes 1 and 2 (INSIG1 and 2)9,10. A
drop in cholesterol in the ER membrane leads to a conforma-
tional change in SCAP11,12, which leads to dissociation from
INSIG and facilitates COPII-mediated trafficking of the SCAP-
SREBP complex to the Golgi13–15. In the Golgi, SREBP is pro-
teolytically activated through sequential cleavage by the proteases
S1P and S2P16,17 (encoded by MBTPS1 and MBTPS2), which
release the transcriptionally active N-terminal domain of SREBP.
Translocation of this domain to the nucleus leads to transcrip-
tional activation of target genes containing an SRE. As SREBPs
contain an SRE in their promoter region, they induce their own
expression in a positive feedback mechanism4,18.
The final step in the SCAP-SREBP cycle is the less-well
understood COPI-mediated retrograde transport of SCAP from
the Golgi to the ER, which allows SCAP to reiteratively associate
with newly synthesized SREBPs and INSIGs in the ER19. To
identify unknown determinants of the SREBP pathway we
applied a set of mammalian haploid genetic screens and report
here the identification of the SREBP Regulating Gene SPRING
(C12ORF49), as a previously unrecognized factor that governs
SREBP activity in mammalian cells and in vivo in mice by con-
trolling the level of functional SCAP.
Results
Haploid genetic screens link SPRING to the SREBP pathway.
The SREBP pathway is subject to exquisite regulation by a core
set of molecular factors that include INSIGs, SCAP, MBTPS1, and
MBTPS22. To identify unknown SREBP regulators we developed
two SREBP-focused mammalian haploid genetic screens. Using
this approach, we interrogated SREBP signaling in an unbiased
manner reasoning that any unknown regulator should be found
in independent screens.
In the first screen, we evaluated the cholesterol-dependent regu-
lation of SQLE, a rate-limiting enzyme in cholesterol biosynthesis
and a bona fide transcriptional target of SREBP220,21. To monitor
the level of SQLE protein in live cells as a proxy for SREBP activity
we engineered Hap1 cells in which we introduced mNeon into the
last coding exon of the endogenous SQLE locus using CRISPR/
Cas9-based microhomology-mediated end-joining integration
(Fig. 1a and Supplementary Fig. 1A). Consistent with SREBP-
dependent regulation of SQLE expression, the level of the SQLE-
mNeon fusion protein was low in Hap1-SQLE-mNeon cells when
cultured in sterol-containing medium yet was markedly increased
upon sterol-depletion (Fig. 1b, c). Moreover, similar to untagged
SQLE, the levels of chimeric SQLE-mNeon protein were subject to
cholesterol-stimulated proteasomal degradation (Supplementary
Fig. 1B). Using this cell line, we screened for positive genetic
regulators that are required for SREBP signaling as well as for
negative determinants essential for cholesterol-mediated degrada-
tion of SQLE22,23, as illustrated in Fig. 1d. Briefly, following
mutagenesis, Hap1-SQLE-mNeon cells were first sterol-depleted
and subsequently treated with water-soluble cholesterol to induce
SQLE-mNeon degradation. Mutants with the 5% lowest and
highest mNeon signal were isolated by FACS and the integration
sites retrieved from genomic DNA and mapped, as previously
reported24. Validating our screening approach, we identified
strong enrichment of gene-trap insertions in the SQLE locus in the
mNeonLOW population, alongside a similar enrichment in the
established positive regulators of the SREBP pathway SCAP,
MBTPS1, MBTPS2, and SREBF2 itself (Fig. 1e). Conversely, the
strongest negative regulator of SQLE-mNeon found in our screen
was the E3 ubiquitin ligase MARCH6, and its cognate E2 partner
UBE2J2, which we have recently reported to be critical deter-
minants of cholesterol-dependent degradation of SQLE25–27.
Additionally, as expected our screen also identified INSIG1, an
established negative regulator of the SREBP pathway. As such, this
screen faithfully reports on cholesterol-dependent regulation of
SQLE by the SREBP pathway. Amongst the known core SREBP
activating genes, identified as positive regulators of SQLE
expression, we also found an uncharacterized gene, C12ORF49,
which is further referred to as SREBP-Regulating Gene (SPRING).
In a parallel screen, we leveraged our recent finding that
Hap1 cells tolerate loss of the key de novo fatty acid synthesis
enzyme, FASN, which is a canonical SREBP1-regulated gene24.
We reasoned that in the absence of FASN and fatty acid synthesis
Hap1 cells must rely on alternative survival pathways for acquiring
fatty acids and growth. To test this idea, we generated independent
Hap1-FASNKO cells (Supplementary Fig. 2A) and conducted a
synthetic lethality screen, as previously reported28. Briefly, Hap1-
FASNKO cells were mutagenized and expanded in culture for
12 days to allow depletion of lethal mutations. Synthetic genetic
interactions were thereafter analyzed by comparing the results
obtained in Hap1-FASNKO cells and WT Hap1 cells treated in the
same manner. A total of 72 genes showed a synthetic genetic
interaction in Hap1-FASNKO cells (Fig. 1f). Amongst these, a
prominent SREBP signature encompassing the gene encoding
SREBP2 itself, SREBF2, the genes encoding the core SREBP-
activation machinery (SCAP, MBTPS1, and MBTPS2) and the
uncharacterized gene SPRING were apparent in Hap1-FASNKO
cells. Notably, these genes appeared to be non-essential in WT
Hap1 cells. Additionally, a set of SREBP target genes including
LDLR, ACSL1, ACSL3, and FABP5, that are implicated in lipid
uptake, trafficking, and metabolism also displayed a synthetic
interaction in Hap1-FASNKO cells (Supplementary Fig. 3A). These
observations suggest that in the absence of FASN, Hap1 cells
depend on SREBP-dependent lipid uptake and further support the
idea that SPRING may be implicated in SREBP signaling.
Previously, we have reported a haploid genetic screen that
revealed that the entry of Andes viruses into target cells critically
depends on SREBP signaling and on the presence of cholesterol in
the host-cell membrane29. When integrating the three SREBP-
focused haploid screens we identify a core set of 5 shared genes
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necessary for SREBP signaling that next to SREBF2, SCAP,
MBTPS1, MTBPS2 also includes SPRING (Fig. 1g). In aggregate,
our three independent screens strongly point towards SPRING
acting as a positive regulator of the SREBP pathway to govern
lipid metabolism.
SPRING is a determinant of the SREBP pathway in cells. As
SPRING was identified in three independent screens in conjunc-
tion with the core SREBP activation machinery we reasoned that it
could play a role in SREBP-mediated transcriptional control of
lipid metabolism. To test this, we engineered Hap1 cells lacking
SPRING and tested their response to sterol-depletion (Fig. 2a, b).
Cells lacking SPRING had reduced protein levels of the SREBP
targets SQLE, SQS, and INSIG1 under basal culture conditions,
and were unable to increase abundance of these under sterol-
depletion condition. Similarly, in contrast to control Hap1 cells
which, as expected, robustly increased the mRNA expression of the
SREBP-transcriptional targets HMGCR, LDLR, SQLE, and FASN
in response to sterol-depletion, in Hap1-SPRINGKO cells basal
expression of these genes was reduced and the response to sterol-
depletion was largely abrogated. Notably, mRNA and protein
levels of SPRING were not sensitive to the cellular sterol status.
As a functional consequence, Hap1-SPRINGKO cells exhibited
markedly reduced levels of surface LDLR protein and failed to
increase LDL uptake under sterol-deprived conditions (Fig. 2c, d
and Supplemental Fig. 2E). Importantly, regulation of the SREBP


















































































































Fig. 1 Haploid mammalian genetic screens identify SPRING as an SREBP regulator. a Schematic illustration of CRISPR/Cas9-mediated targeting of the
endogenous SQLE locus for in-frame integration of mNeon-2A-PURO. b Hap1 control and Hap1 SQLE-mNeon cells were cultured in the presence or
absence of sterols and total cell lysates were immunoblotted as indicated. c Hap1 SQLE-mNeon cells were grown as in b on coverslips and subsequently
fixed and counterstained with DAPI (nucleus). Cells were imaged and representative images are shown; scale bar, 25 μm. d Schematic depiction of SQLE-
mNeon screen: a library of mutant Hap1 SQLE-mNeon cells was cultured in sterol-depletion medium for 24 h to induce SQLE expression. During the last 6 h
β-methyl-cyclodextrin-cholesterol was added to initiate sterol-stimulated degradation of SQLE after which mNeonHIGH and mNeonLOW cells were isolated
by FACS. e The log mutational index-scores (see Methods section) were plotted against the number of trapped alleles per gene. Statistically significant hits
(p < 0.05) in the isolated mNeonHIGH and mNeonLOW cell populations are indicated in yellow and blue, respectively. f Comparison of gene-essentiality
screens between control Hap1 cells and Hap1-FASNKO cells. Per gene, the ratio of sense/total orientation gene-trap insertions (y-axis) and the total
number of insertions in a particular gene (x-axis) are plotted. FASN synthetic lethality screens show that SCAP, SREBF2, MBTPS1/2, and SPRING are
significantly depleted in FASNKO cells. g Venn diagram indicating the number of unique and commonly identified genes in 3 individual SREBP-focused
screens. b, c Representative images of three independent experiments are shown.
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pathway was not restricted to Hap1 cells but was also observed in
hepatocytes, which represent a physiological model for SREBP
activity. Similar to our finding in Hap1 cells, loss of Spring in
murine Hepa1-6 hepatoma cells and in primary mouse hepato-
cytes attenuated activity of the SREBP pathway (Fig. 2e and Sup-
plementary Fig. 4).
Proteolytic processing of SREBPs is a prerequisite for their
function as transcription factors, raising the possibility that
SPRING may govern SREBPs at the level of their processing
(Fig. 2f). Notably, we found that proteolytic processing of
SREBP2 can occur in the absence of SPRING. However, we
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and mature (i.e., processed) protein level of SREBP2, and
consequentially the level of its target genes in the absence of a
change in the level or localization of Site 1 Protease (Supple-
mentary Fig. 2B). We also considered the possibility that
proteolytic cleavage by S1P or S2P could be affected by loss of
SPRING. Similar to SREBPs, the ER-stress-related factor ATF6
undergoes proteolytic processing by these two proteases30. We,
therefore, tested whether basal- and Tunicamycin-induced ER
stress signaling is altered in the absence of SPRING (Supple-
mentary Fig. 2C). Basal ER-stress, as evaluated by expression of
ATF6-driven genes and other ER stress-related genes, was not
changed in cells lacking SPRING. Importantly, induction of ER
stress by Tunicamycin, which promotes ATF6 translocation to
the Golgi and subsequent proteolytic processing by S1P/S2P
proteases was intact, albeit we did observe a small yet significant
reduction. This suggests that the S1P/S2P axis is not globally
abrogated in cells lacking SPRING and can still respond to
physiological cues.
We also considered the possibility that loss of SPRING may
result in an intrinsic lesion in SREBP activity (e.g., if it is directly
required for transcriptional activation of SREBP). Yet this does
not seem to be the case, as when we introduce an N-terminal
constitutively active SREBP2 transcriptional domain into Hap1-
SPRINGKO cells we were able to restore the basal and sterol-
depletion-induced levels of SQLE (Fig. 2g). To evaluate the
consequence of absence of SPRING we compared the transcrip-
tional profile of Hap1-WT and Hap1-SPRINGKO cells (Fig. 3a
and Supplementary Fig. 3B). This comparison confirmed the
aberrant activation of the SREBP pathway in Hap1-SPRINGKO
cells. We, therefore, proceeded to compare the global transcrip-
tional response of these cells to sterol-depletion (Fig. 3b, c). While
Hap1-WT increased expression of a panel of SREBP-regulated
target genes in response to sterol depletion, in the absence of
SPRING the expression of these genes was refractory to this
treatment. Importantly, the SREBP program could be restored by
reintroducing SPRING in sterol-depleted Hap1-SPRINGKO cells
(Fig. 3d). Collectively, this set of experiments establishes SPRING
as a determinant of SREBP activation in mammalian cells.
Spring attenuates hepatic SREBP signaling in vivo. Spring is
ubiquitously expressed in mouse tissues with slightly higher
expression in the liver and kidney (Supplementary Fig. 5A). To
study whether our observation in cells extends to the in vivo
setting and to investigate the physiological role of Spring, we
generated Spring(−/−) mice using CRISPR/Cas9 technology.
Guide RNAs were designed to target the 5′ region of coding exon
2 and the 3′ region of coding exon 5. We obtained heterozygous
mice with a deletion spanning exons 2 until 5 (Fig. 4a). However,
heterozygous crosses failed to produce viable homozygous
knockout offspring (Fig. 4b). The genetic distribution of offspring
was, in fact, consistent with loss of Spring being embryonic lethal
and suggesting a critical role for Spring in mouse development.
We confirmed this notion by analyzing embryos obtained in
heterozygous crosses. We did observe abnormally developed
embryos at day 7.5 dpc. These embryos were smaller and showed
a poorly developed amniotic cavity and allantois in comparison
with the adjacent to normally developing embryos in the mouse
uterine horn. The abnormal embryos were confirmed to be
homozygous null mutants by PCR genotyping (Supplementary
Fig. 5B, C).
As we were unable to study constitutive Spring(−/−) mice due
to early embryonic lethality, we opted to study the consequence of
adenoviral-mediated temporal silencing of hepatic Spring expres-
sion. Following transduction, mice were fasted overnight and
subsequently refed for 6 h to maximally induce SREBP signaling.
Under this setting, effective Spring silencing resulted in significant
reduction of Srebf2 and a panel of its downstream transcriptional
targets Hmgcs, Hmgcr, Sqs, Dhcr24, Pcsk9, and Ldlr (Fig. 4c).
Notably, Srebf1 and its target genes Fasn, Scd1, and Acc were
unchanged. In this experimental setting no differences were
observed in hepatic and plasma lipids. These results provide an
indication that Spring regulates SREBP signaling in vivo and has a
crucial physiological role during embryogenesis.
SPRING is a glycosylated Golgi-resident membrane protein.
SPRING encodes for a 205 amino acid protein with no apparent
homology to other proteins and is predicted to have a possible
signal peptide, a single transmembrane-spanning domain, and a
cysteine-rich motif (Fig. 5a). To gain insight into how SPRING
influences SREBP activity we determined its cellular localization.
We first considered the possibility that SPRING may be a secreted
protein. However, our analysis indicates that this is not the case,
but that SPRING is associated with cellular membranes (Sup-
plementary Fig. 6A, B). In transfected HeLa cells SPRING
was predominantly co-localized with the Golgi marker GM130
(Fig. 5b). Consistent with glycosylation of SPRING, N-glycosidase
(PNGase-F) removed glycans from SPRING protein (Supple-
mentary Fig. 6C). Further, mutation of the single predicated
glycosylation site (Asn-67) abolished SPRING glycosylation
(Fig. 5c). To interrogate the nature of the glycan chain present on
SPRING we used Endoglycosidase-H (Endo-H), which removes
glycans from ER- and cis/medial Golgi-resident proteins, before
they acquire complex modifications31. We observed that unlike
LDLR, SPRING glycosylation remained Endo-H-sensitive (Sup-
plementary Fig. 6D). Together with the observed localization of
SPRING in the Golgi (Fig. 5b), sensitivity to Endo-H suggests that
SPRING is present in the cis/medial Golgi, which is where
the SCAP-SREBP-S1P machinery is located32,33. To determine
the topology of SPRING in the Golgi membrane we performed
protease protection assays. Unlike LDLR-HA, which has its
C-terminus exposed to the cytoplasm and is hence sensitive to
tryptic digestion, SPRING-V5 was refractory (Fig. 5d). Permea-
bilization of cellular membranes with Triton X-100 rendered
SPRING-V5 sensitive to tryptic digestion. In aggregate with our
observation on SPRING glycosylation, these results indicate that
the C-terminus of SPRING faces the Golgi lumen.
Fig. 2 Ablation of SPRING reduces SREBP signaling in cell lines and primary mouse hepatocytes. a, b Hap1-WT and Hap1-SPRINGKO cells were cultured
in the presence or absence of sterols. Subsequently, cells were harvested for a gene expression analysis by qPCR as indicated (N= 5 biologically
independent samples), and b immunoblotting as indicated (N= 3). c, d Cells were grown as in a, b and were (c) stained with an anti-LDLR-APC antibody,
or d incubated with 5 µg/ml DyLight 488-labeled LDL for 1 h. Subsequently, cells were fixed and analyzed by FACS (N= 3 biologically independent
samples). e Primary mouse hepatocytes were isolated from C57BL/6J WT and Cas9 knock-in mice and 4 h post isolation infected with Ad-3x -sgRNA-
Spring adenoviral particles. Cells were sterol-depleted for 16 h and harvested for immunoblotting and gene expression analysis as indicated (N= 3
biologically independent samples). f Schematic representation of SREBP processing (left). Total cell lysates from Hap1-WT and Hap1-SPRINGKO cells were
immunoblotted as indicated (right). A representative image of at least three independent experiments is shown. g Hap1-WT and Hap1-SPRINGKO cells
were transduced with a FLAG-tagged constitutively active SREBP2 N-terminal construct. Total cell lysates were immunoblotted as indicated (N= 2). All
bars and errors represent mean ± SEM; *p < 0.05, **p < 0.01, ***p < 0.001.
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Intrigued by the fact that cholesterol-sensing by SCAP occurs
initially in the ER, we asked whether delivery of SPRING to the
Golgi compartment was an absolute requirement for its ability to
regulate SREBP activation. To address this, we generated a
SPRING expression construct with a C-terminal (i.e., lumen-
facing) ER-retention KDEL signal34 (SPRINGKDEL). SPRINGKDEL
was largely retained in the ER, as evident by co-localization with
the ER marker protein VAMP-associated protein A (VAPA,
Fig. 5e). In contrast to WT SPRING, which could rescue sterol-
dependent regulation of SQLE when introduced into Hap1-
SPRINGKO cells, SPRINGKDEL failed to do so (Fig. 5f). Taken
together, these results demonstrate that regulation of SREBP
activity by SPRING requires its Golgi localization.
SPRING governs SCAP localization in cells. Trafficking to and
subsequent proteolytic processing of SREBPs in the Golgi is cri-
tically dependent on a stoichiometric interaction with SCAP7,8.
Although the levels of SREBP are drastically decreased, SREBP
processing can still occur in SPRINGKO cells (c.f. Fig. 2a, b, f).
We, therefore, considered the possibility that SCAP function may
be affected by SPRING. Regulation of SCAP retention in the ER
requires interaction with INSIGs. This prompted us to investigate
whether akin to INSIG, SPRING also interacts with SCAP. We
used a co-immunoprecipitation approach and found that SCAP
can interact with SPRING when the two are over-expressed in a
model system (Fig. 6a). With this assay, we are unable to formally
establish the cellular localization of this interaction. However, we
point out that using the same approach we were unable to detect
an interaction between SPRING and INSIG. The potential func-
tional significance of the SCAP-SPRING interaction was then
evaluated in CHO cells that stably produce SCAP-eGFP (CHO-
SCAP-eGFP)35 in which Spring was ablated by CRISPR/Cas9-
mediated genome editing. In control cells grown in sterol-
containing media SCAP-eGFP was predominantly located in the
ER and localization markedly shifted towards the Golgi upon
sterol-depletion (Fig. 6b and Supplementary Fig. 7A). However,
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Fig. 3 Global SREBP-signaling requires SPRING. a–d Comparison of transcriptional profiles obtained by RNAseq of a Hap1-WT and Hap-SPRINGKO cells,
and b–d the transcriptional response of the indicated cells to sterol depletion. SREBP target genes (HMGCR, HMGCS1, SQLE, ACACA, ACAT2, ACSS2,
CYP51A1, DHCR24, DHCR7, EBP, FASN, FDFT1, FDPS, GGPS1, GGPS1, HSD17B7, IDI1, INSIG1, LDLR, LSS, MVD, MVK, NSDHL, PCSK9, SC5D, SCD1, SREBF2,
TM7SF2)4,18 are shown in red and SPRING in green.
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a Mus musculus 2410131K14Rik-201
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Fig. 4 SPRING is essential for mouse embryogenesis and for hepatic SREBP signaling. a Illustration of the genomic organization of murine SPRING
(2410131K14Rik-201) and the allele obtained after CRISPR/Cas9 editing. The 5’ and 3’ gRNAs are indicated in red and green, respectively. Sanger
sequencing of amplified genomic DNA was performed to confirm the deletion of exons 2–5. b Table showing an overview of the obtained genotypes from
various crosses of heterozygous mice. *p < 0,005, lower than expected by Pearson’s Chi-square test with 2 df; **equal to expected when assuming
embryonic lethality of homozygous null mice, Chi-square= 2.37, 0.9 > p > 0.1 with 1 df. c WT C57BL/6J mice were administered Ad-shCtrl or Ad-shSpring
(N= 8/5 animals per group, respectively) via tail-vein injection. After 7 days, mice were fasted overnight and subsequently refed for 6 h. Total liver RNA
was isolated and expression of the indicated genes was determined by qPCR. Each individual mouse is plotted within the box and whiskers plot that depicts
the median line, the 25th and 75th percentile, and the min-max values. *p < 0.05, ***p < 0.001.
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the Golgi irrespective of the cellular sterol status. Importantly,
ER-localization of SCAP-eGFP could be restored in the
SPRINGKO cells grown in the presence of sterols by introducing
back SPRING expression. Mislocalization of SCAP to the Golgi in
SPRINGKO cells likely results in depletion of functional SCAP in
the ER, which is required at stoichiometric levels to support exit
of SREBP towards the Golgi. However, these experiments were
conducted with cells that stably over-produce SCAP-eGFP, and
are thus highly suitable to track SCAP localization, but may mask
effects on SCAP protein level. We. therefore. evaluated endo-
genous SCAP protein in Hap1 cells (Fig. 6c and Supplementary
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SPRINGKO cells. This is consistent with functional SCAP defi-
ciency in these cells, and implies that increasing the level of SCAP
should overcome the SREBP-signaling defect in SPRINGKO
cells. In line with this idea we found that introducing SCAP into
Hap1 SPRINGKO cells, similar to introducing back SPRING,
fully restored the SREBP2-mediated sterol-dependent response
(Fig. 6d). Functionally, introduction of SCAP was sufficient to
restore LDL uptake and de novo cholesterol biosynthesis (Fig. 6e,
f and Supplementary Fig. 7B).
Finally, it is well recognized that intact SREBP signaling is
required for cell growth and proliferation. Moreover, there is
increasing evidence that cancer cells activate SREBP signaling as a
means to produce lipids to support their rapid growth3,36. We,
therefore, interrogated the Dependency Map (DepMap, www.
depmap.org) repository which aims to identify genetic vulner-
abilities in human cancer37,38. Within the database of 342 cancer
cell lines (27 distinct lineages) that were subjected to genome-
wide CRISPR/Cas9 lethality, SPRING expression emerged as a
selective gene in 337/342 of the evaluated cell lines (Supplemen-
tary Fig. 8A). This suggests that a wide-variety of tumor cells is
dependent on SPRING expression for growth. Remarkably, in this
panel of cell lines the top co-dependent genes with SPRING were
those associated with the core SREBP machinery (Supplementary
Fig. 8B), mirroring our haploid genetic screen results. This
observation lends further support for a central role for SPRING
in regulating the SREBP pathway and its potential role in
proliferative diseases. Collectively, our in vitro and in vivo
findings support the idea that SPRING is a Golgi-resident factor
required for maintaining SCAP function, and that loss of SPRING
results in functional depletion of SCAP in the ER and attenuation
of SREBP signaling (Supplementary Fig. 9).
Discussion
The SREBP transcriptional network is a central determinant of
homeostatic lipid metabolism. Dysregulation of this pathway
underlies development of human conditions, exemplified by
development of hypercholesterolemia and ensuing coronary artery
disease due to mutations in the SREBP-regulated gene LDLR25.
Therefore, elucidating the mechanisms that govern the SREBP
pathway is of outmost importance. Genetic approaches have been
paramount in clarifying the molecular components that control
cholesterol and fatty acid metabolism that are regulated by
SREBPs26. Mammalian haploid genetic screens have been applied
to interrogate a variety of cellular processes and phenotypes,
amongst others, pathogen entry27,39–42, signal transduction24,
modes of toxin action43, and gene essentiality28. Yet this metho-
dology is also well suitable to address lipid-associated questions,
and accordingly we recently applied this approach to investigate
the control of sterol-stimulated degradation of HMGCR44. In this
study, by combining three independent SREBP-related screens we
identify SPRING (C12ORF49) as a previously uncharacterized
regulator of the SREBP pathway.
SPRING is a Golgi-resident glycosylated membrane protein
and together with its orthologs forms an uncharacterized protein
family (Pfam UPF0454), which bears no substantial homology
with other human proteins. We found that the primary pheno-
type of cells lacking SPRING is decreased basal levels of precursor
and mature SREBPs and SREBP signaling, and an inability to
enhance SREBP signaling so as to mount a homeostatic response
to sterol-depletion. This is highly reminiscent of what is observed
in cells lacking SCAP45 and in liver-specific Scap knockout
mice46. Accordingly, we have narrowed the primary lesion in
SREBP signaling in SPRINGKO cells to SCAP functionality.
Namely, in SPRINGKO cells SCAP levels are reduced and the
protein is trapped in the Golgi irrespective of the cellular sterol
status. Consequentially, ectopic over-expression of SCAP rescues
SREBP signaling in SPRINGKO cells, in line with functional
depletion of SCAP in the ER. The COPII-mediated anterograde
transport of SCAP from the ER to the Golgi is well-studied2,32,47.
However, despite being an essential part of SCAP’s life cycle, the
molecular determinants and events that govern its Golgi activity
and eventual retrograde COPI-mediated trafficking back to the
ER have received only limited attention19,48.
Upon delivery to the Golgi, the SCAP-SREBP complex is
tethered to PAQR349. The interaction between SCAP and PAQR3
anchors the complex to the Golgi and is necessary to support
proteolytic activation of SREBP and hepatic lipid synthesis.
Cleavage by S1P is also a perquisite to release SCAP for COPI-
mediated retrograde transport to the ER, as pharmacological or
genetic inhibition of this process prevents SCAP retrograde
trafficking, and instead directs SCAP towards lysosomal degra-
dation48. The phenotype of SPRINGKO cells is consistent with the
potential involvement of SPRING in the process of retrograde
transport of SCAP. Retrieval of proteins to the ER is classically
dependent on the presence of a C-terminus -KKXX or -KDEL
sequence34, both of which are absent in SCAP. Yet as these are
also absent in SPRING we find it unlikely that SPRING directly
acts as a retrieval adaptor protein. Alternatively, it is possible that
SPRING is a licensing factor that is required for directing SCAP
towards retrograde transport, possibly by releasing it from
PAQR3 or other retention signals. However, PAQR3 was not
identified in our screens, possibly reflecting functional redun-
dancy between the 11 PAQR family members50, or cell-type
specific differences. It is also formally possible that SPRING
governs SCAP by controlling the fraction that is directed towards
the degradative pathway. Absence of SPRING, akin to preventing
S1P-dependent cleavage of SREBP48, could result in functional
depletion of SCAP. Our observation that the ATF6-mediated
stress response - which like SREBP activation requires the
sequential proteolytic processing by S1P and S2P yet does not
require SCAP - is also reduced in the absence of SPRING provides
support for this scenario and may explain reduced SCAP protein
level in SPRINGKO cells. As such, SPRING could influence
additional processes beyond modulating SCAP and the SREBP
pathway. Finally, while speculative, it is intriguing to consider a
potential role for SPRING’s cysteine-rich motif in its function.
Notably, the cysteine-rich domain present in the ectodomain of
the Hedgehog receptor Smoothened was recently reported to
Fig. 5 Localization of SPRING to the Golgi is required for regulation of SREBP. a Schematic depiction of SPRING’s predicted domains and post-
translational modifications (www.uniprot.org). b HeLa cells were transfected with a SPRING-GFP expression construct. Subsequently, cells were
counterstained against the Golgi-resident protein GM130. DAPI was used to stain the nuclei; scale bar, 10 μm. c HEK293T cells were transfected with
expression constructs encoding SPRING WT or a N67Q mutant. Total cell lysates were immunoblotted as indicated (N= 3). d HEK293T cells were co-
transfected with expression constructs encoding LDLR-HA and SPRING-V5. Cellular membranes were isolated and subjected to tryptic digestion in the
presence or absence of the permeabilizing detergent Triton-X-100. An equal amount of protein was immunoblotted as indicated. e Immunofluorescence
staining of Hap1 cells transfected with expression constructs encoding SPRING-mCherry or SPRING-mCherry-KDEL and nuclei were counterstained with
DAPI; scale bar, 25 μm. f Hap1-WT and Hap-SPRINGKO cells were transfected as indicated and total cell lysates immunoblotted as shown (N= 2).
b, d, e Representative images of three independent experiments are shown.
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Fig. 6 SPRING modulates SCAP function. a HEK293T cells were transfected with the indicated expression constructs. Total cell lysates and
immunoprecipitated fractions were analyzed by immunoblotting as indicated (N= 3). While we determined that SPRING was detected in the co-IP fraction
with SCAP, its level was not enriched in this fraction relative to the level in total cells. b Representative fluorescence images of CHO-SCAP-eGFP-WT and
CHO-SCAP-eGFP-SPRINGKO cells cultured in the presence or absence of sterols; scale bar, 10 μm. See also Supplementary Fig. 7A. Representative images
of three independent experiments are shown. c An equal amount of crude membrane fractions from Hap1-WT and Hap1-SPRINGKO cells were
immunoblotted as indicated (N= 4), with GM130 serving as loading control. d, e Hap1-WT and Hap-SPRINGKO cells that stably express SPRING or SCAP
were treated as indicated and d total cell lysates were immunoblotted as indicated (N= 3), and e fluorescent LDL uptake was measured by FACS (N= 3
biologically independent samples). Note that the first 4 bars are from Fig. 2d and are shown for comparison. f Hap1-WT and Hap-SPRINGKO cells that
stably express SPRING, SCAP, or GFP were cultured for 24 h in medium containing 10% LPDS, 3 mM β-methyl-cyclodextrin, and 13C2-Sodium acetate (N= 3
biologically independent samples/group). Following lysis incorporation of 13C2-acetate into cholesterol was determined by mass-spectrometry as
described in the Methods section. All bars and errors represent mean ± SEM; *p < 0.05, ***p < 0.001.
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directly bind cholesterol, and this was sufficient to induce
receptor activation51,52. While the Smoothened and SPRING
cysteine-rich domains differ in the number and organization of
cysteines, it is possible that binding of cholesterol, or a related
sterol, to this motif is required for regulation of SPRING function.
Possibly, binding of a sterol to this domain may result in a
regulatory conformational change akin to that occurring in
SCAP11. Evidently, addressing these possibilities and the detailed
mechanism by which SPRING regulates the SREBP pathway will
require the development of novel sensitive and quantitative assays
to monitor, amongst others, SCAP trafficking.
To demonstrate that our findings in cells extend to a physio-
logical in vivo setting we developed Spring knockout mice. Genetic
ablation of Spring resulted in early embryonic lethality demon-
strating that Spring is required for embryonic development in
mice. The embryonic lethality associated with Spring ablation is
similar to that observed in mouse models of Srebf1 and Srebf2
deletion53,54, albeit in these models embryonic lethality is not
absolute. Whether the lethality observed in Spring(−/−) embryos is
related to its role in lipid metabolism remains to be investigated.
Using adenoviral-mediated silencing of hepatic Spring expression
we found marked attenuation of SREBP2 signaling in the liver,
with limited effect on the SREBP1 pathway. The effect on SREBP2
is similar to the phenotype observed in liver- or intestine-specific
Scap knockout mice46,55, but the latter was somewhat unexpected
given our results in primary hepatocytes and cell lines, and the
functional requirement of an intact SREBP2 pathway to drive the
SREBP1-controlled genetic program53,56. This could possibly be
due to the short-term duration of the experiment, to the presence
of residual Spring mRNA expression, or the lack of a dietary
challenge. Nevertheless, these results demonstrate that Spring is a
regulator of the SREBP program in vivo in mice.
Finally, genetic variation in components of the SREBP genetic
program, such as in the LDLR, PCSK9, and HMGCR, is associated
with lipid traits in humans57. It remains to be seen whether
genetic variation in SPRING contributes to lipid traits and asso-
ciated diseases in humans. Our bioinformatic analysis suggests
that a wide-variety of human tumor cells display dependency on
expression of a core set of SREBP-centered genes, including
SPRING, for their growth thereby expanding the potential
involvement of SPRING to other lipid-associated conditions. In
conclusion, we report here the identification of SPRING as a
previously unrecognized regulator of the SREBP program. Our
in vitro and in vivo findings warrant further studies to evaluate
the contribution of SPRING to lipid metabolism.
Methods
Chemicals. Simvastatin sodium salt was purchased from Calbiochem. All other
reagents (including 13C2 sodium acetate and methyl-β-cyclodextrin) were pur-
chased from Sigma.
Cell lines and cell culture. HeLa, Hepa1-6, and HEK293T cells were obtained
from the ATCC and cultured in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum (FBS) and 10,000 U/mL
penicillin–streptomycin (Gibco) in a humidified atmosphere at 37 °C and 5% CO2.
Hap1 cells were cultured similarly but in Iscove’s modified Eagle’s medium
(IMDM). CHO-SCAP-eGFP cells (a kind gift from Peter Espenshade, John
Hopkins, USA) were cultured in a 1:1 mixture of Ham’s F-12 medium and
DMEM supplemented with 5% FBS and 10,000 U/mL penicillin–streptomycin in a
humidified atmosphere at 37 °C and 8% CO2, as previously described35,58. For
sterol-depletion cells were cultured in sterol-depletion medium (DMEM, IMDM,
or DMEM/F12) supplemented with 10% lipoprotein-deficient serum (LPDS),
2.5 μg/mL simvastatin, and 100 μM mevalonate as indicated and previously
described59. For specifically evaluating cholesterol synthesis, cells were cultured in
medium supplemented with 10% LPDS and 3mM β-methyl-cyclodextrin and cell
viability was monitored using the MTT assay. To generate Hepa1-6 murine
hepatocytes that stably produce Cas9 (Hepa1-6-Cas9), cells were transduced with a
lentiviral construct encoding Cas9 and subsequently individual clones were selected
and expression of Cas9 verified. Mouse hepatocytes expressing Cas9 were isolated
from Cas9 knock-in mice60,61 (#02857, The Jackson Laboratory) and cultured as
described previously61. Hepatocytes from wildtype (WT) littermates were used as
control WT cells.
Generation of FASNKO and SPRINGKO cells. To ablate expression of FASN and
SPRING in human cell lines we used CRISPR/Cas9-mediated genome editing as
previously described62. Briefly, guide RNAs (sgRNAs) targeting an exon-coding
region of the respective each gene were designed and cloned into px330 (Addgene
#42230). The sequences of the sgRNAs are shown in Supplementary Data 1.
Subsequently, cells were transfected and independent clones obtained after selec-
tion. To ablate Spring in CHO-SCAP-eGFP cells sgRNAs targeting hamster Spring
or the safe-harbor locus Ppp1R12c were cloned into lentiCRISPRv2 (Addgene
#52961). Lentiviral particles were produced in HEK293T cells and used to trans-
duce and select individual clones CHO-SCAP-eGFP clones. Proper genome editing
in all individual clones was confirmed by sequencing. To target Spring in mouse
primary WT or Cas9 expressing hepatocytes, cells were isolated and cultured as
described above. Cells were infected 4 h post isolation with Ad-3xsgRNA-Spring at
an MOI of 20 for 24 h. Subsequently, cells were washed and sterol-depleted for 16 h
after which cells were harvested for immunoblotting and gene expression analysis.
To ablate Spring in Hepa1-6-Cas9 cells were infected similarly at an MOI of 50
for 96 h.
Generation of Hap1 SQLE-mNeon cells. To insert the mNeon-2A-PURO reporter
cassette into the endogenous SQLE locus we used microhomology-based CRISPR/
Cas9-CRIS-PITCh methodology63. Briefly, this technique allows integration of a
mNeon-2A-PURO cassette into the ultimate coding exon of SQLE and subsequent
selection of puromycin resistant clones, as we have recently reported for
HMGCR44. The donor fragment containing the microhomology and mNeon-2A-
PURO sequences, as well as the sgRNA sequences are shown in Supplementary
Data 1 and 2. Independent clones were expanded and genome editing was con-
firmed by sequencing, immunoblotting, and immunofluorescence.
Human haploid genetic screens. FASN fitness screen. Hap1 FASNKO cells were
mutagenized as previously described28. In brief, retroviral gene-trap virus was
produced in HEK293T cells. 40 million Hap1 FASNKO cells were transduced using
virus combined from multiple harvests on 3 consecutive days. The obtained
mutagenized library was cultured for 12–14 days while maintaining at least 4-fold
library complexity. Afterward, cells were fixed with BD Fix buffer I (BD Bios-
ciences) and stained for DNA content using 5 µg/mL propidium iodide (PI). To
ensure that only gene-trap insertions in haploid cells are analyzed, cells were sorted
by FACS for G1 phase. Genomic DNA was isolated using the Qiagen DNA iso-
lation kit. Insertions were mapped according to the protocol described in Blomen
et al.28.
SQLE-mNeon screen. In order to identify regulators of SQLE we prepared a
library of mutagenized Hap1-SQLE-mNeon cells using a gene-trap retrovirus
expressing blue fluorescent protein (BFP), as described previously28,64. Briefly, 5 ×
108 Hap1-SQLE-mNeon cells were seeded and transduced with virus from two
combined harvests on three consecutive days in the presence of 8 µg/mL protamine
sulfate (Sigma). Mutagenized cells were expanded to thirty T175 flasks at a
confluence of ~80%. Subsequently, cells were cultured in sterol-depletion medium
for a total of 24 h and with 50 µg/ml β-methyl-cyclodextrin-cholesterol (Sigma)
during the last 6 h to stimulate cholesterol-dependent degradation of SQLE-
mNeon. At the end of this treatment. the cells were washed twice with PBS,
dissociated with TrypLE (Thermo Fisher), pelleted, and fixed with BD Fix Buffer I
(BD biosciences) for 10 min at 37 °C. After washing twice with PBS containing 10%
FCS, the cells were filtered through a 40 µm strainer (BD FalconTM) before sorting
two populations of cells (i.e. SQLE-mNeonLOW and SQLE-mNeonHIGH) that
represent ~5% of the lowest and highest SQLE-mNeon expressing cells from the
total cell population, respectively. In addition, in order to reduce potential
confounding effects of diploid cells, which are heterozygous for alleles carrying
gene-trap integrations, the cells were sorted in parallel for haploid DNA content
(G1 phase) by staining with propidium iodide. Cell sorting was carried out on a
Biorad S3 Cell sorter until ~10 million cells of each population were collected.
Sorted cells were pelleted and genomic DNA was isolated using a DNA mini kit
(Qiagen). To assist de-crosslinking of genomic DNA the cell pellets were
resuspended in PBS supplemented with Proteinase K (Qiagen) followed by
overnight incubation at 56 °C with lysis buffer AL (Qiagen) with continuous
agitation. Gene-trap insertion sites of each sorted cell population were amplified
using a Linear Amplification polymerase chain reaction (LAM-PCR) on the total
yield of isolated genomic DNA28. Samples were subsequently submitted for deep
sequencing and insertion sites were mapped and analyzed as previously
described44,64.
Molecular cloning and generation of adenoviral particles. The full human
SPRING open reading frame was amplified from Hap1 and HepG2 cDNA (RefSeq
NM_024738) and sub-cloned into pDONR221 (Invitrogen) or pENTR1A-GFP
(Invitrogen) to create pDONR221-SPRING and pENTR-SPRING-GFP, respec-
tively. The resulting entry constructs were used to generate pLenti6.3-SPRING and
pLenti6.3-SPRING-GFP following LR gateway recombination with pLenti6.3-
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DEST (Invitrogen). Site directed mutagenesis was used to introduce an N67Q
mutation in pDONR221-SPRING. pDONR221-SPRING and pDONR221-
SPRINGN67Q were used to generate pDEST47-SPRING and pDEST47-
SPRINGN67Q, respectively. SPRING cDNA was also cloned into the retroviral
vector pBABE-PURO (Addgene #1764). mCherry (derived from pmCherry-C1
(Clontech)) was cloned at the C-terminus of SPRING (separated by an alanine
linker) to create pBABE-SPRING-mCherry. Additionally, a C-terminal FLAG tag
was added to pBABE-SPRING (separated by a AAV linker) to create pBABE-
SPRING-FLAG. A KDEL retention signal (5’-AAGGACGAGTTG-3’) was added to
the C-terminus of pBABE-SPRING-mCherry and pBABE-SPRING-FLAG to create
pBABE-SPRING-mCherryKDEL and pBABE-SPRING-FLAGKDEL, respectively.
The pcDNA-SCAP-GFP and pcDNA4-SCAP-MycHis plasmids were a kind gift
from Andrew Brown65 (Sydney University, Australia). SCAP-MycHis was ampli-
fied from pcDNA4-SCAP-MycHis, cloned into pENTR1A (Invitrogen), and sub-
sequently recombined into pLenti6.3-DEST (Invitrogen) using Gateway cloning.
All plasmids were verified by sequencing and transfected into cells using JetPrime
reagent (Polyplus) according to the manufacturer’s protocol. To generate Ad-
3xsgRNA-Spring adenoviral particles a geneblock containing 3 guide RNAs tar-
geting murine Spring under the control of U6 promoters was ordered (Invitrogen,
Supplementary Data 3). The geneblock fragment was cloned into pDONR221
(Invitrogen) and recombined into pAD/PL-DEST (Invitrogen) using Gateway
recombination. To generate pAd-shSpring oligonucleotides targeting 3 different
coding regions of Spring were cloned into pTER+/pENTR (Addgene #430-1) that
has been modified by addition of a CMV-GFP cassette (Supplementary Data 1).
The resulting pTER+/pENTR-GFP-shSpring or pTER+/pENTR-GFP-shScram-
bled were recombined into pAD-BLOCK-iT (Invitrogen) using Gateway cloning,
tested, and the most effective one used. Adenoviral particles were generated and
evaluated as previously reported59, and amplified, purified and tittered (Viraquest).
Immunofluorescence. Hap1 and HeLa cells were seeded on poly-L-lysine (Sigma
Aldrich) coated cover slips. After indicated treatments, cells were washed three
times with ice-cold PBS and fixed using 4% paraformaldehyde (Sigma Aldrich
F8775). Cells were permeabilized in 0.1% Triton X-100 (Sigma), blocked with 5%
BSA (Sigma) and stained with the following primary antibody for 16 h: VAPA (a
kind gift from Sjaak Neefjes, Leiden University Medical Center, the Netherlands,
1:200), and GM130 (Cell Signaling 12480, 1:1000). Secondary antibodies con-
jugated with Alexa-Fluor-568 or Alexa-Fluor-488 were used (Thermo Fisher,
1:400). CHO-SCAP-eGFP cells were plated as above and transfected with
Calnexin-mCherry and Giantin-mScarlet expression plasmids to label the ER and
Golgi compartments, respectively (plasmids were a kind a gift from Eric Reits and
Joachim Goedhart, University of Amsterdam). Cells were subsequently treated as
indicated. DAPI was added during incubation with the secondary antibodies in 5%
BSA/PBS for 1 hr at room temperature. Cover slips where washed three times for
20 minutes and mounted on standard glass slides. Imaging was performed on a
Leica SP5 confocal microscope using LCS software.
Immunoblotting, deglycosylation assay, and co-IP. Total cell lysates were pre-
pared in RIPA buffer (150 mM NaCl, 1% NP-40, 0.1% sodium deoxycholate, 0.1%
SDS, 100 mM Tris-HCl, pH 7.4) supplemented with protease inhibitors (Roche).
Lysates were cleared by centrifugation at 4 °C for 10 min at 10,000 × g. Subse-
quently, cleared lysates were separated on NuPAGE Novex 4–12% Bis-Tris gels
(Invitrogen) and transferred to nitrocellulose membranes. Membranes were probed
with primary antibodies, which are listed in Supplementary Data 4. Secondary
horseradish peroxidase-conjugated antibodies (Invitrogen) were used and visua-
lized with chemiluminescence on a LAS4000 (GE Healthcare). In some experi-
ments proteins were fractionated before immunoblotting as previously reported66.
For evaluating N-glycosylation, dithiothreitol (DTT) was added to total cell lysates
to a final concentration of 50 mM. Subsequently, lysates were heated to 95 °C for
5 min and after cooling recombinant Peptide-N-Glycosidase F (PNGase-F) (Pro-
mega) was added at a concentration of 1 unit/µL. The mixture was incubated for
3 h at 37 °C before analysis by immunoblotting. Similar de-glycosylation assays
using Endoglycosidase H (EndoH) (NEB) were done according to the manu-
facturer’s protocol. For co-immunoprecipitation (Co-IP) experiments, total cell
lysates were prepared in NP-40 buffer (150 mM NaCl, 5 mM EDTA, 1% NP-40,
50 mM Tris-HCl, pH 7.4) supplemented with protease inhibitors (Roche) and
incubated overnight at 4 °C with the indicated antibodies and protein A/G-mag-
netic Dynabeads (Thermo Fisher) according to the manufacturer’s instructions.
Beads were collected using a DynaMag magnet (Thermo Fisher) and washed three
times with lysis buffer. Bound proteins were eluted and analyzed by immuno-
blotting. As loading controls Actin (1:3000), GM130 (1:1000) or Cdk4 (1:1000)
were used and all shown immunoblots are representative of at least 3 independent
experiments unless otherwise indicated.
Protease protection assay. To determine SPRING topology, an equal amount of
isolated cellular membranes was treated with trypsin as described previously67.
Briefly, membranes were incubated with the indicated amounts of trypsin in the
presence or absence of Triton X-100 for 30 min at 30 °C. Reactions were stopped by
the addition of loading buffer and heat inactivation at 95 °C for 10 min. Subse-
quently, samples were analyzed by immunoblotting as indicated above.
RNA isolation and qPCR. Total RNA was isolated from cells using a Direct-zol
RNA MiniPrep kit (Zymo Research). One microgram of total RNA was reverse
transcribed using a cDNA synthesis kit (Biotool). SensiFAST SYBR (Bioline) was
used for real-time quantitative qPCR (qPCR) performed on a LightCycler 480 II
system (Roche). Gene expression levels were normalized to the expression level of
36B4. Primer sequences are listed in Supplementary Data 5.
RNAseq analysis. Two biological replicates of mutant cell lines were analyzed
using standard RNAseq methodology. Briefly, cells were cultured in complete
medium or sterol-depleted for 16 h, and then scraped in TriZol. A sequencing
library was prepared according to standard Illumina RNA-seq protocols. Libraries
were multiplexed, clustered and sequenced on an Illumina HiSeq 2500. To visualize
data, reads were normalized, averaged and displayed using PRISM software.
Mouse experiments. C57BL/6J mice (Charles River) and Rosa26-LSL-Cas9
knock-in mice (#02857, The Jackson Laboratory) were fed a standard chow diet
and housed in a temperature-controlled room under a 12-hour light-dark cycle
under pathogen-free conditions. For adenoviral infections, age-matched
(8–10 weeks old) male mice were injected with 3 × 109 PFU by tail-vein injection.
8 days later, mice were fasted (overnight) for 16 h and then refed a standard chow
diet for an additional 6 h. At the time of sacrifice, liver tissue was collected and
immediately frozen in liquid nitrogen and stored at −80°. Liver tissue was pro-
cessed for isolation of RNA and protein as described above. To assess the tissue
distribution of Spring, the indicated tissues were collected from 3 individual 12 wk
old male C57BL/6J mice. All handling of mice was according to institutional AMC
guidelines and regulations and approved by the local ethics committee. The gen-
eration of Spring knock-out mice was performed under the supervision and with
the approval of the animal committee at The Netherlands Cancer Institute and
comply with local and international regulations and ethical guidelines. Briefly, Cas9
mRNA and two gRNAs targeting the 5’ of exon 2 (5’-TGCCATCCGATGCAAT
GCGCAGG-3’) and the 3’ of exon 5’ (5’-AGGCAAGTTGGGCGTACTGCTGG-3’)
were injected in zygotes. To identify the edited allele PCR was performed using
primers Fw: 5’-CCCAGATTGCCTTCCCACAG-3’ and Rv 5’- ATTACGCTGTG
ATCCCCACA-3’. For genotyping and phenotyping of single embryos, 7.5 dpc
(days postcoitum) embryos were obtained together with the uterine horns. The
tissues were fixed in EAF (ethanol/acetic acid/formaldehyde) and embedded in
paraffin, from which 2 µm- and 10 µm-thick sections were made for pathologic
analysis, and for genomic DNA isolation by laser-guided microdissection for PCR
analysis, respectively. All animal procedures (handling, experiments, and genera-
tion of Spring−/− mice) were approved by the relevant ethics committee.
LDL uptake assay. The production of DyLight488-labeled LDL and LDL uptake
assays were done as previously described68. Briefly, Hap1 cells were plated and
washed twice with PBS on the following day. Subsequently, LDL uptake was
initiated by incubating cells with 5 µg/ml DyLight488-labeled LDL in IMDM
supplemented with 0.5% BSA for 1 h at 37 °C. Cells were then washed twice with
PBS supplemented with 0.5% BSA, dissociated, and resuspended in FACS buffer
(2 mM EDTA, 0.5% BSA in PBS). Cells were then fixed with 4% paraformaldehyde
and cellular LDL uptake was determined by flow cytometry on a CytoFLEX Flow
cytometer (Beckman Coulter). Intact cells were gated by standard FSC vs
SSC gating
Surface LDLR assay. To determine the level of surface LDLR, cells were treated as
indicated in the figure legends, dissociated using Accutase (STEMCELL technol-
ogies), and washed once with FACS buffer (2 mM EDTA, 0.5% BSA in PBS).
Subsequently, cells were stained with an Allophycocyanin (APC)-conjugated
mouse anti-human LDLR antibody (R&D; #472413, 10 µl/1 × 106 cells) according
to the manufacturer’s instructions. Subsequently, cells were washed three times
with FACS buffer, fixed with 4% paraformaldehyde (PFA) and analyzed on a
CytoFLEX Flow cytometer (Beckman Coulter). Intact cells were gated by standard
FSC vs SSC gating. Relative surface LDLR levels were calculated from mean values
after correction for background signal.
Cholesterol synthesis assay. Hap1 control and Hap1-SPRINGKO cells were
cultured in 6-well plates in IMDM supplemented with 10% LPDS, 3 mM β-methyl-
cyclodextrin and 5 mM 13C2-Sodium Acetate for 24 h. Cells were then washed
twice with ice-cold PBS, once with 0.9% NaCl followed by addition of 1 mL of ice-
cold methanol. For the extraction of sterols cells were scraped and transferred to a
2 mL tube, sonicated with a tip sonicator at 8 Watt and 40 Joule and centrifuged at
14,000 × g for 10 minutes at 4 °C. The supernatant was transferred to a new 1.5 mL
tube and evaporated under nitrogen. The dried extract was dissolved in 100 µL
methanol and analyzed by an ultra-high-pressure liquid chromatography system
(Thermo Scientific) with an Acquity UPLC HSS T3, 1.8 µm particle diameter
(Waters, Milford Massachusetts, USA) coupled to a Thermo Q Exactive Plus
Orbitrap mass spectrometer with an atmospheric-pressure chemical ionization
(APCI) source. The column was kept at 30 °C and the flow rate was 0.2 mL/min.
The mobile phase was composed of 100% methanol and the gradient was isocratic
for a total runtime of 15 min. Data was acquired in full-scan positive ionization
mode. Data interpretation was performed using the Xcalibur software (Thermo
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Scientific). 13C enrichment was calculated based on mass distribution isotopomer
analysis (MIDA) and all results were corrected for natural 13C abundance as
described69.
Statistics. Statistical analyses were performed with the Prism software package V6.
Results were evaluated by two-sided Student’s t-test when comparing two groups.
When 2 or more groups were compared One-way analysis of variance (ANOVA)
was used in combination with Tukey’s test for multiple comparisons. For knockout
mice, the significance of the observed frequencies of genotypes in relation to the
expected numbers was analyzed by Pearson’s Chi-square test. In the adenoviral
experiment, one mouse was excluded as the majority of the measured values were
identified as outliers (Grubbs test, α= 0.1). All measurements were taken from
distinct samples. SEM is indicated by error bars and p values are indicated by
asterisks: *p < 0.05, **p < 0.01 and ***p < 0.001.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Source data for the figures are provided with the paper, and additional data are available
from the corresponding author upon reasonable request. RNAseq datasets are available
from GEO (GSE143530). The genetic screens are available at https://phenosaurus.nki.nl
and the corresponding raw DNA datasets are available from SRA (BioProject ID:
596944). Source image data underlying Figs. 1b, 2b, e, 5c, d, 6a, c, and d and
Supplementary Figs. 1B, 2B, D, 4B, C, 6A, B, C and D are provided as a Source Data File.
The numerical data underlying Figs. 2a, c, d, e, 4c, 6e, and f and Supplementary Figs. 2C,
D, 4A are provided as a Source Data File.
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